Jiangsu Jibeier Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 5.72%

Jiangsu Jibeier Pharmaceutical Co Ltd (688566) has an Asset Resilience Ratio of 5.72% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Jiangsu Jibeier Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥151.01 Million

≈ $22.10 Million USD Cash + Short-term Investments

Total Assets

CN¥2.64 Billion

≈ $386.27 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2024)

This chart shows how Jiangsu Jibeier Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See 688566 book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Jiangsu Jibeier Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Jiangsu Jibeier Pharmaceutical Co Ltd stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥151.01 Million	5.72%
Total Liquid Assets	CN¥151.01 Million	5.72%

Asset Resilience Insights

Limited Liquidity: Jiangsu Jibeier Pharmaceutical Co Ltd maintains only 5.72% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Jiangsu Jibeier Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Jiangsu Jibeier Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Regencell Bioscience Holdings Ltd NASDAQ:RGC	Drug Manufacturers - Specialty & Generic	43.05%
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	Drug Manufacturers - Specialty & Generic	20.44%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Henan Newland Pharmaceutical Co. Ltd. A SHE:301277	Drug Manufacturers - Specialty & Generic	31.63%
Hainan Shuangcheng Pharmaceut SHE:002693	Drug Manufacturers - Specialty & Generic	3.29%

Annual Asset Resilience Ratio for Jiangsu Jibeier Pharmaceutical Co Ltd (2021–2024)

The table below shows the annual Asset Resilience Ratio data for Jiangsu Jibeier Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	2.22%	CN¥56.00 Million ≈ $8.19 Million	CN¥2.53 Billion ≈ $369.86 Million	+0.63pp
2023-12-31	1.58%	CN¥35.00 Million ≈ $5.12 Million	CN¥2.21 Billion ≈ $323.34 Million	-3.00pp
2022-12-31	4.58%	CN¥90.00 Million ≈ $13.17 Million	CN¥1.96 Billion ≈ $287.48 Million	-6.42pp
2021-12-31	11.00%	CN¥200.00 Million ≈ $29.27 Million	CN¥1.82 Billion ≈ $266.13 Million	--

pp = percentage points

About Jiangsu Jibeier Pharmaceutical Co Ltd

SHG:688566 China Drug Manufacturers - Specialty & Generic

Market Cap

$817.12 Million

CN¥5.58 Billion CNY

Market Cap Rank

#10075 Global

#2861 in China

Share Price

CN¥28.00

Change (1 day)

+0.14%

52-Week Range

CN¥23.90 - CN¥42.20

All Time High

CN¥51.60